A phase II study of lenalidomide in patients with relapsed or refractory ATLL

被引：0
|
作者：
Adrienne A Phillips
Jalanni Giddings
Steven M Horwitz
机构：
[1] Herbert Irving Cancer Center,Division of Medical Oncology, Department of Medicine
[2] Herbert Irving Cancer Center,Department of Medicine
[3] Memorial Sloan Kettering Cancer Center,undefined
来源：
Retrovirology | / 11卷 / Suppl 1期
关键词：
Median Survival; Thrombocytopenia; Median Number; Evaluable Patient; Single Institution;
D O I：
10.1186/1742-4690-11-S1-P4
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] A Phase I Study of Lenalidomide and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
    Griffiths, Elizabeth A.
    Brady, William
    Tan, Wei
    Vigil, Carlos E.
    Thompson, James E.
    Ford, Laurie A.
    Dickey, Noelle M.
    Sperrazza, Jill
    Wang, Eunice S.
    Wetzler, Meir
    BLOOD, 2014, 124 (21)
  • [42] A Phase II LYSA Study of Obinutuzumab Combined with Lenalidomide for Relapsed or Refractory Aggressive B-Cell Lymphoma
    Morschhauser, Franck
    Cartron, Guillaume
    Salles, Gilles A.
    Bijou, Fontanet
    Fruchart, Christophe
    Bouabdallah, Krimo
    Feugier, Pierre
    Le Gouill, Steven
    Tilly, Herve
    Molucon-Chabrot, Cecile
    Maerevoet, Marie
    Casasnovas, Rene-Olivier
    Van den Neste, Eric W.
    Zachee, Pierre
    Van Eygen, Koen
    Van Hoof, Achiel
    Bonnet, Christophe
    Haioun, Corinne
    Andre, Marc
    Xerri, Luc
    Houot, Roch
    BLOOD, 2016, 128 (22)
  • [43] A Phase I Study of Nivolumab and Lenalidomide in Relapsed/ Refractory B Cell Lymphoma
    Bond, David A.
    Yildiz, Vedat
    Wei, Lai
    Alinari, Lapo
    William, Basem M.
    Brammer, Jonathan E.
    Christian, Beth A.
    Blum, Kristie A.
    Maddocks, Kami J.
    BLOOD, 2019, 134
  • [44] A PHASE I STUDY OF VORINOSTAT, LENALIDOMIDE, AND DEXAMETHASONE FOR RELAPSED AND REFRACTORY MULTPLE MYELOMA
    Richardson, P.
    Weber, D.
    Mitsiades, C.
    Dimopoulos, M.
    Harousseau, J. L.
    Howe, J.
    Graef, T.
    Gause, C.
    Byrne, C.
    Anderson, K.
    Siegel, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 155 - 156
  • [45] Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia
    Wendtner, Clemens-Martin
    Hillmen, Peter
    Mahadevan, Daruka
    Buehler, Andreas
    Uharek, Lutz
    Coutre, Steven
    Frankfurt, Olga
    Bloor, Adrian
    Bosch, Francesc
    Furman, Richard R.
    Kimby, Eva
    Gribben, John G.
    Gobbi, Marco
    Dreisbach, Luke
    Hurd, David D.
    Sekeres, Mikkael A.
    Ferrajoli, Alessandra
    Shah, Sheetal
    Zhang, Jennie
    Moutouh-de Parseval, Laure
    Hallek, Michael
    Heerema, Nyla A.
    Stilgenbauer, Stephan
    Chanan-Khan, Asher A.
    LEUKEMIA & LYMPHOMA, 2012, 53 (03) : 417 - 423
  • [46] Combined Vorinostat, Lenalidomide and Dexamethasone Therapy in Patients with Relapsed or Refractory Multiple Myeloma: A Phase I Study
    Siegel, David
    Weber, Donna M.
    Mitsiades, Constantine S.
    Dimopoulos, Meletios A.
    Harousseau, Jean-Luc
    Rizvi, Syed
    Howe, Jason
    Reiser, David
    Byrne, Catriona
    Anderson, Kenneth C.
    Richardson, Paul
    BLOOD, 2009, 114 (22) : 129 - 129
  • [47] A phase 1 study of lenalidomide and ibrutinib in combination with rituximab in relapsed and refractory CLL
    Ujjani, Chaitra
    Wang, Hongkun
    Skarbnik, Alan
    Trivedi, Neel
    Ramzi, Pari
    Khan, Nadia
    Cheson, Bruce D.
    BLOOD ADVANCES, 2018, 2 (07) : 762 - 768
  • [48] A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Phase I results.
    Lunning, Matthew Alexander
    Ruan, Jia
    Nair, Sumithra
    Boruchov, Adam M.
    Byrne, Regina
    Gerecitano, John F.
    Hamlin, Paul A.
    Inserra, Beth
    Leonard, John
    Lynch, Peggy
    Matasar, Matthew J.
    Moskowitz, Alison J.
    Moskowitz, Craig
    Myskowski, Patricia L.
    Nolan, Patrick
    Palomba, Maria Lia
    Quefeld, Christiane
    Straus, David J.
    Zelenetz, Andrew David
    Horwitz, Steven M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [49] COMBINED VORINOSTAT, LENALIDOMIDE AND DEXAMETHASONE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: A PHASE I STUDY
    Siegel, D.
    Weber, D.
    Mitsiades, C.
    Dimopoulos, M.
    Harousseau, J.
    Rizvi, S.
    Howe, J.
    Reiser, D.
    Anderson, K.
    Richardson, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 155 - 155
  • [50] A Phase I Study of Bendamustine Combined with Lenalidomide and Dexamethasone in Patients with Refractory or Relapsed Multiple Myeloma.
    Lentzsch, Suzanne
    O'Sullivan, Amy
    Lalo, Silvana
    Kruppa, Carrie
    Gardner, Diane
    Kennedy, Ryan C.
    Burt, Steve
    Mapara, Markus Y.
    Redner, Robert
    Roodman, David
    Volkin, Robert L.
    Zonder, Jeffrey
    BLOOD, 2009, 114 (22) : 736 - 736
12345